|
 |
哥伦布、匹兹堡及各地消息
|
| |
Ohio's Mass Vaccination Clinic in Cleveland to
Offer Johnson & Johnson Vaccine Next Week
|
|
|
(COLUMBUS, Ohio)—Ohio
Governor Mike DeWine announced today that Ohio's state-federal mass
vaccination clinic in downtown Cleveland will offer the Johnson &
Johnson vaccine next week. Anyone age 18 or older may receive the
single-dose Johnson & Johnson vaccine from Tuesday, May 11, through
Monday, May 17.
The clinic, located at Cleveland State University's Wolstein Center
at 2000 Prospect Avenue, accepts walk-ins from 8 a.m. to 7 p.m.
Appointments can also be booked online at
gettheshot.coronavirus.ohio.gov or by calling 833-4-ASK-ODH.
The mass vaccination clinic, which is operating in partnership
between the state of Ohio, Federal Emergency Management Agency, City
of Cleveland, Cuyahoga County, and Cleveland State University,
launched in mid-March. In its first six weeks of operations, more
than 237,000 first and second doses of the Pfizer vaccine were
administered.
The clinic will continue offering first doses of the Pfizer vaccine
to anyone age 16 or older through Monday, May 10. Second doses of
the Pfizer vaccine will be administered beginning on Tuesday, May
18, for those who received their first doses of vaccine at the
Wolstein Center in late April and early May.
Current Wolstein Center Mass Vaccination Clinic Timeline:
Tuesday, March 16 - Monday, April 5: Pfizer first doses
Tuesday, April 6 - Monday, April 26: Pfizer second doses
Tuesday, April 27 - Monday, May 10: Pfizer first doses
Tuesday, May 11 - Monday, May 17: Johnson & Johnson single doses
Tuesday, May 18 - Monday, May 31: Pfizer second doses
The clinic may extend beyond May 31 if demand for vaccine in a mass
vaccination setting warrants that the clinic continue. There are
currently more than 1,100 other local area providers offering
vaccines across the state.
Administration of the Johnson & Johnson vaccine was paused in Ohio
last month as the Centers for Disease Control and Prevention's (CDC)
Advisory Committee on Immunization conducted a thorough review of
extremely rare blood-clotting events reported to the Vaccine Adverse
Event Reporting System. The CDC and Food and Drug Administration (FDA)
allowed use of the Johnson & Johnson vaccine to resume on April 23
after comprehensive analysis found that the benefits of the Johnson
& Johnson vaccine outweigh the risks. Providers in Ohio were
permitted to immediately resume administering the Johnson & Johnson
vaccine provided they continue to follow all guidance by the CDC and
FDA. |
|
|
|
 |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|